Something else from my hospital today:

http://www.boston.com/dailydose/2012/11/28/ob...story.html

And a second bit of news: Boston Medical Center researchers are looking for overweight volunteers with heart disease or diabetes to enroll in a clinical trial to test an experimental obesity medication. The drug, called  Contrave, is a combination of two drugs already on the market: bupropion (an antidepressant) and naltrexone (used to help overcome drug or alcohol addiction).

“Both drugs work a little differently to help control appetite and food intake,” said Dr. Amanda Powell, an obesity medicine physician at Boston Medical Center who is helping to conduct the multi-center trial involving 10,000 patients that’s sponsored by manufacturer Orexigen Therapeutics. “The trial is looking to establish long-term safety over two to four years in real-world patients who already have obesity-related problems like heart disease or diabetes.”